Lawsuit has been confirmed & statements by lead researcher at the hospital trial site to more than one journalist confirm person was in the trial, there was a serious adverse event, & they judged it *not* vaccine-associated. No official statement from the trial or regulator...1/2
...According to the person interviewed, India's regulator was informed when it occurred. Until there's a report from the regulator side, we don't know official status or whether other regulators were notified. (Thank you to everyone tweeting me links to coverage in India.)
...PS: There have been multiple public statements prior to this development from the institution running the trial that there had been no serious adverse events. Hopefully the regulator will sort this out & report publicly soon.
...Reported confirmation from official source of that serious adverse event on Indian trial of Oxford/AstraZeneca vaccine, deemed not vaccine-associated. Spokesperson from the Indian Council of Medical Research: thehindubusinessline.com/news/icmr-says… Open question whether FDA, MHRA &c notified
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This is utterly appalling. The manufacturer of the Oxford/AstraZeneca vaccine in India, @SerumInstIndia, is *suing* the trial participant who lodged a claim for compensation after experiencing a serious adverse event for damage to their reputation thehindu.com/news/national/… ... 1/2
..The trial participant has the right to sue for compensation. While the company is denying the severe event was vaccine-related, they are not denying it happened, contradicting previous statements eg "zero hospitalisation" livemint.com/science/health… & hindustantimes.com/videos/htls/si… 2/3
...Recap: trials of the Oxford/AstraZeneca vaccine were put on pause for investigation by regulators the other 2 times there was a severe adverse event (SAE) - standard practice. This participant was in intensive care & we're only hearing about it because he sued... 3/4
Oh no. 😥 Last week a participant in Indian trial for the Oxford/AstraZeneca vaccine sought compensation for a serious neurological adverse event. Local principal investigator: "we don’t think the adverse event was related to the vaccine."
1/4 economictimes.indiatimes.com/industry/healt… HT @abledoc
...That quote seems to confirm there was an SAE, but I think we need further confirmation. Would be 3rd neurological SAE made public, first 2 in UK trial: 1 of which judged not to be related to the vaccine; for the other, cause was not clear after extensive investigation... 2/4
... The participant's legal action, which will be taken to court next week, alleges participants weren't informed of the risk & the trial wasn't paused when it happened... 3/4
BNT CEO Sahin looking confident. End of October prediction for BNT/Pfizer vaccine? "We're now end of Oct, beginning of Nov; that means it won't be long now till the first so-called read-out". 🤞 (My translation, watching tape from Fri night live interview) tagesspiegel.de/wissen/antrag-…
...*If* the effectiveness & safety data look good, Sahin ⬆️ expects lodging an application for FDA approval by mid-November; the process to clear pre-phase 3 data has already begun in Europe. First batches have been produced, but haven't cleared quality control yet.
...Ideally, Sahin said, antibodies would completely stop any of the virus getting into the cells, but you have to assume some virus will make it past them. That's when you need T-cells to step in & kill the virus, & make any disease milder. So a good vaccine needs to induce both